These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15930991)

  • 1. Staging and treatment of advanced esophageal cancer.
    von Rahden BH; Stein HJ
    Curr Opin Gastroenterol; 2005 Jul; 21(4):472-7. PubMed ID: 15930991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and therapy in advanced cancer of the esophagus and the gastroesophageal junction.
    Lerut T; Coosemans W; Decker G; De Leyn P; Moons J; Nafteux P; Van Raemdonck D
    Curr Opin Gastroenterol; 2006 Jul; 22(4):437-41. PubMed ID: 16760764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of integrated computed tomography positron-emission tomography in esophageal cancer: staging and assessment of therapeutic response.
    Erasmus JJ; Munden RF
    Semin Radiat Oncol; 2007 Jan; 17(1):29-37. PubMed ID: 17185195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis, diagnosis and therapeutic possibilities of esophageal cancer.
    Siersema PD
    Curr Opin Gastroenterol; 2007 Jul; 23(4):456-61. PubMed ID: 17545786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is positron emission tomography useful in locoregional staging of esophageal cancer? Results of a multidisciplinary initiative comparing CT, positron emission tomography, and EUS.
    Sandha GS; Severin D; Postema E; McEwan A; Stewart K
    Gastrointest Endosc; 2008 Mar; 67(3):402-9. PubMed ID: 18178202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy.
    Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA; Eloubeidi MA
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1232-41. PubMed ID: 15942562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography.
    Pfau PR; Perlman SB; Stanko P; Frick TJ; Gopal DV; Said A; Zhang Z; Weigel T
    Gastrointest Endosc; 2007 Mar; 65(3):377-84. PubMed ID: 17321235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staging in oesophageal cancer.
    Plukker JT; van Westreenen HL
    Best Pract Res Clin Gastroenterol; 2006; 20(5):877-91. PubMed ID: 16997167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolving role of PET-CT in the management of esophageal cancer.
    Chuang HH; Macapinlac HA
    Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):201-9. PubMed ID: 19293768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging laparoscopy in gastric cancer. Accuracy and impact on therapy.
    Muntean V; Mihailov A; Iancu C; Toganel R; Fabian O; Domsa I; Muntean MV
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):189-95. PubMed ID: 19565050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in nasopharyngeal carcinoma.
    Guigay J
    Curr Opin Oncol; 2008 May; 20(3):264-9. PubMed ID: 18391624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy.
    Kim TJ; Kim HY; Lee KW; Kim MS
    Radiographics; 2009; 29(2):403-21. PubMed ID: 19325056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer.
    Krause BJ; Herrmann K; Wieder H; zum Büschenfelde CM
    J Nucl Med; 2009 May; 50 Suppl 1():89S-96S. PubMed ID: 19380406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett's esophagus.
    Pech O; May A; Günter E; Gossner L; Ell C
    Am J Gastroenterol; 2006 Oct; 101(10):2223-9. PubMed ID: 17032186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.
    Meyers BF; Haddad F; Siegel BA; Zoole JB; Battafarano RJ; Veeramachaneni N; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 2006 Apr; 131(4):822-9; discussion 822-9. PubMed ID: 16580440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET.
    Sloof GW
    Best Pract Res Clin Gastroenterol; 2006; 20(5):941-57. PubMed ID: 16997171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of neoadjuvant therapy for esophageal adenocarcinoma.
    Ku GY; Ilson DH
    Surg Oncol Clin N Am; 2009 Jul; 18(3):533-46. PubMed ID: 19500742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does FDG-PET add information to EUS and CT in the initial management of esophageal cancer? A prospective single center study.
    McDonough PB; Jones DR; Shen KR; Northup PG; Galysh RL; Hernandez A; White GE; Kahaleh M; Shami VM
    Am J Gastroenterol; 2008 Mar; 103(3):570-4. PubMed ID: 17941963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of locally advanced esophageal cancer with surgery and chemoradiation.
    Siersema PD; van Hillegersberg R
    Curr Opin Gastroenterol; 2008 Jul; 24(4):535-40. PubMed ID: 18622172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic evaluation and palliation of pancreatic adenocarcinoma: current and future options.
    Pausawasdi N; Scheiman J
    Curr Opin Gastroenterol; 2007 Sep; 23(5):515-21. PubMed ID: 17762557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.